American Epilepsy Society Annual Meeting

Shifting to a Holistic Approach to Treat Developmental Epileptic Encephalopathies

December 13, 2021

The medical director of the Epilepsy program at the University of Toronto discussed her presentation at AES 2021 regarding the need to change how clinicians view and treat patients with developmental epileptic encephalopathies.

Ganaxolone’s Potential in TSC, Need for More Drug Development: Darcy Krueger, MD, PhD

December 12, 2021

The director of the Tuberous Sclerosis Clinic at Cincinnati Children’s discussed the phase 2 open-label study of ganaxolone in TSC and whether drug development remains the top priority for these patients. [WATCH TIME: 3 minutes]

Recent Advances, Future Developments in Epilepsy Surgery: Imad Najm, MD

December 10, 2021

The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute spoke on the latest advances with epilepsy surgery, as well as what still needs to be learned. [WATCH TIME: 5 minutes]

Takeaways From AES 2021: Imad Najm, MD

December 09, 2021

The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute discussed poignant presentations from the 2021 American Epilepsy Society Annual Meeting. [WATCH TIME: 7 minutes]

Cenobamate’s Efficacy Profile in Treating Seizures: William Rosenfeld, MD

December 09, 2021

The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed numerous presentations from AES 2021 that bolstered cenobamate’s known efficacy and safety profile. [WATCH TIME: 7 minutes]